Quick Answer
ICU MEDICAL INC/DE reported Gross Profit of $822.04 million for the year ending 2025.
- ICU MEDICAL INC/DE showed a decrease of -0.3% in Gross Profit from 2024 to 2025.
- This data is from ICU MEDICAL INC/DE's annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: $36.03 million | Q2 2014: $37.54 million | Q3 2014: $38.15 million | Q4 2014: $39.69 million | Q1 2015: $42.51 million | Q2 2015: $43.76 million | Q3 2015: $46.27 million | Q4 2015: $48.26 million | Q1 2016: $49.23 million | Q2 2016: $50.13 million | Q3 2016: $51.27 million | Q4 2016: $50.76 million | Q1 2017: $88.95 million | Q2 2017: $88.06 million | Q3 2017: $111.60 million | Q4 2017: $137.49 million | Q1 2018: $149.00 million | Q2 2018: $151.80 million | Q3 2018: $134.59 million | Q4 2018: $134.64 million | Q1 2019: $135.30 million | Q2 2019: $103.87 million | Q3 2019: $118.55 million | Q4 2019: $114.14 million | Q1 2020: $121.42 million | Q2 2020: $106.28 million | Q3 2020: $113.92 million | Q4 2020: $119.87 million | Q1 2021: $112.68 million | Q2 2021: $123.53 million | Q3 2021: $127.79 million | Q1 2022: $168.83 million | Q2 2022: $167.59 million | Q3 2022: $186.40 million | Q1 2023: $192.04 million | Q2 2023: $192.33 million | Q3 2023: $183.92 million | Q1 2024: $185.24 million | Q2 2024: $207.43 million | Q3 2024: $204.85 million | Q1 2025: $210.11 million | Q2 2025: $208.06 million | Q3 2025: $200.88 million.
- Over the full 18 years of available data (2008 to 2025), ICU MEDICAL INC/DE's Gross Profit has grown by 815.2%.
- Historical annual values: Fiscal year 2025: $822.04 million | Fiscal year 2024: $824.78 million | Fiscal year 2023: $739.87 million | Fiscal year 2022: $697.76 million | Fiscal year 2021: $491.49 million | Fiscal year 2020: $461.50 million | Fiscal year 2019: $471.86 million | Fiscal year 2018: $570.03 million | Fiscal year 2017: $426.10 million | Fiscal year 2016: $201.40 million | Fiscal year 2015: $180.80 million | Fiscal year 2014: $151.40 million | Fiscal year 2013: $154.73 million | Fiscal year 2012: $156.51 million | Fiscal year 2011: $142.35 million | Fiscal year 2010: $128.97 million | Fiscal year 2009: $106.28 million | Fiscal year 2008: $89.82 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: